Skip to main content
FinSpry Logo
FinSpry
SOLV logo
SOLV
(NYSE)
Solventum Corporation
$74.73-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Solventum (SOLV) Stock Price & Financial Analysis

Solventum Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$72.74 - $76.30
52-Week High$88.20
52-Week Low$62.38
Open$74.49
Volume1.32M
Average Volume (3M)1.43M
Market Cap13.35B
Shares Outstanding175.30M
P/E Ratio (TTM)8.37
Forward P/E4.29
Price to Sales (P/S)1.56
Price to Book (P/B)2.58
EV/EBITDA6.52
Revenue (TTM)8.32B
Net Income (TTM)1.56B
Free Cash Flow (TTM)-10.00M
EPS (TTM)$8.88
Profit Margin18.69%
Operating Margin25.81%
Return on Equity (ROE)30.82%
Debt to Equity1.00
50-Day MA$67.71
200-Day MA$73.79
52-Week Change-0.91%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Solventum

What is the current stock price for SOLV?

As of the latest trading session, SOLV stock trades at $76.13. The 52-week range is $62.38–$88.20, with a day range of $72.74–$76.30.

What is the P/E ratio for SOLV?

Solventum's trailing P/E ratio is 8.4, meaning investors pay $8.4 for every $1 of annual earnings. The forward P/E is 4.3, reflecting analyst expectations for future earnings. Solventum operates in the Healthcare sector.

Does SOLV pay dividends?

Solventum does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for SOLV?

Based on 5 analysts, the consensus for SOLV is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of SOLV?

Solventum's market capitalization is $13.35B, classifying it as a large-cap company. Solventum operates in the Healthcare sector within the Medical Instruments & Supplies industry.